Research and Markets: Ankylosing Spondylitis Pipeline Highlights 2014-2017

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/wxdvx3/ankylosing) has announced the addition of the "Ankylosing Spondylitis Pipeline Highlights - 2015" report to their offering.

The latest report Ankylosing Spondylitis Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Ankylosing Spondylitis market. It covers emerging therapies for Ankylosing Spondylitis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Ankylosing Spondylitis pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Ankylosing Spondylitis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Ankylosing Spondylitis pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which Ankylosing Spondylitis pipeline products will be launched in the US and Ex-US till 2017.

Key Topics Covered:

1. Ankylosing Spondylitis Pipeline by Stages

2. Ankylosing Spondylitis Pipeline by Drug Class

3. Ankylosing Spondylitis Pipeline by Company

4. Ankylosing Spondylitis Phase 3 Clinical Trial Insights

5. Ankylosing Spondylitis Phase 2 Clinical Trial Insights

6. Ankylosing Spondylitis Phase 1 Clinical Trial Insights

7. Ankylosing Spondylitis Preclinical Research Insights

8. Ankylosing Spondylitis Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information visit http://www.researchandmarkets.com/research/wxdvx3/ankylosing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals